508 related articles for article (PubMed ID: 2124245)
1. Long-term follow-up of 120 patients with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.
Rozenbaum W; Gharakhanian S; Navarette MS; De Sahb R; Cardon B; Rouzioux C
J Invest Dermatol; 1990 Dec; 95(6 Suppl):161S-165S. PubMed ID: 2124245
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Evans LM; Itri LM; Campion M; Wyler-Plaut R; Krown SE; Groopman JE; Goldsweig H; Volberding PA; West SB; Mitsuyasu RT
J Immunother (1991); 1991 Feb; 10(1):39-50. PubMed ID: 1826454
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
[TBL] [Abstract][Full Text] [Related]
4. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Fischl MA; Finkelstein DM; He W; Powderly WG; Triozzi PL; Steigbigel RT
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):379-84. PubMed ID: 8601224
[TBL] [Abstract][Full Text] [Related]
6. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
[TBL] [Abstract][Full Text] [Related]
8. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma.
Lane HC; Kovacs JA; Feinberg J; Herpin B; Davey V; Walker R; Deyton L; Metcalf JA; Baseler M; Salzman N
Lancet; 1988 Nov; 2(8622):1218-22. PubMed ID: 2903954
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
[TBL] [Abstract][Full Text] [Related]
10. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.
de Wit R; Schattenkerk JK; Boucher CA; Bakker PJ; Veenhof KH; Danner SA
Lancet; 1988 Nov; 2(8622):1214-7. PubMed ID: 2903953
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and tolerance of low-dose, long-term interferon-alpha 2b and zidovudine in early-stage AIDS-associated Kaposi's sarcoma.
Mauss S; Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):157-62. PubMed ID: 7552479
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study.
Opravil M; Hirschel B; Bucher HC; Lüthy R
Int J STD AIDS; 1999 Jun; 10(6):369-75. PubMed ID: 10414879
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b.
Costa da Cunha CS; Lebbe C; Rybojad M; Agbalika F; Ferchal F; Rabian C; Vignon-Pennamen MD; Calvo F; Morel P
Arch Dermatol; 1996 Mar; 132(3):285-90. PubMed ID: 8607632
[TBL] [Abstract][Full Text] [Related]
15. Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
Podzamczer D; Bolao F; Clotet B; García P; Casanova A; Pagerols X; Gudiol F
J Intern Med; 1993 Mar; 233(3):247-53. PubMed ID: 8095516
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
Baumann R; Täuber MG; Opravil M; Hirschel B; Kinloch S; Chave JP; Pletscher M; Lüthy R
Klin Wochenschr; 1991 May; 69(8):360-7. PubMed ID: 1909399
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study.
Krown SE; Li P; Von Roenn JH; Paredes J; Huang J; Testa MA
J Interferon Cytokine Res; 2002 Mar; 22(3):295-303. PubMed ID: 12034036
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS; Rarick MU; Bernstein-Singer M; Espina BM; Jones B; Montgomery T; Sharma D; Rasheed S; Levine AM
J Biol Response Mod; 1990 Oct; 9(5):512-6. PubMed ID: 2254762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
